First published on ScienceDaily.com

A study led by Massachusetts General Hospital (MGH) investigators may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA (tissue plasminogen activator), the “clot busting” drug that has greatly reduced stroke-related disability and deaths in eligible patients. The report, published online in Annals of Neurology, describes the results of a trial using MR-based imaging technologies to identify patients likely to be within 4.5 hours of stroke onset, even though their initial symptoms had not been witnessed.


read more

First published on ScienceDaily.com

The diagnosis is one that a family never wants to hear: Your father has Alzheimer’s disease. Your mother has stroke-related dementia.

A recently released study, included in a special supplement to the Journal of Gerontology, indicates that dementia’s impact might be compressing a bit. That is, people might be developing dementia later and living with it for a shorter period of time.


read more

First published on ScienceDaily.com

An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.

Rats consuming compound 21 following a clot-based stroke — the most common type in humans — don’t have a smaller stroke size but do have better memory and movement in its aftermath, says Dr. Adviye Ergul, vascular physiologist and Regents’ Professor in the Department of Physiology at the Medical College of Georgia at Augusta University.


read more

First published on ScienceDaily.com

A new computer programme developed by scientists at the Universities of Edinburgh and Glasgow can assess whole brain deterioration and help predict cognitive function after stroke up to ten times more accurately than current methods.

The new approach, published today in the International Journal of Stroke, can quantify visible brain injury from cerebral small vessel disease (SVD) and brain atrophy by translating the million plus bits of information stored in brain scans into a single measure, the “brain health index.”


read more

Brussels, 16 April 2018- The eLearning Module 1 of the Stroke Support Organisation Faculty Tool (SSOFT) is published today at the following address www.ssoft.info.

SSOFT’s first module focuses on the principles around developing and growing SSOs, and is delivered in five sub-modules:

1.1 – What is a Stroke Support Organisation?
1.2 – What is the role of a Stroke Support Organisation?
1.3 – How do you set up a Stroke Support Organisation?
1.4 – Growing your Stroke Support Organisation
1.5 – Stroke Support Organisation networking

The module provides learners with a wealth of knowledge and includes videos, interactive content and activities. Learners will be able to work through the sub-modules at their own pace, earn rewards and share their progress on social media.


read more

Capture from a round table discussion video

In the 30 min round-table discussion video on ESUS, stroke experts (Valeria Caso, Perugia, Danilo Toni, Rome, and Martin Grond, Siegen) discuss the definition of ESUS, diagnostic workup of ischemic stroke and potential implications of the ongoing trials in ESUS.

Embolic stroke of undetermined source (ESUS) is a type of ischemic stroke with unknown origin, i.e. for which no probable cause can be identified after standard diagnostic evaluation. In contrast, the term ‘cryptogenic stroke’ is less well-defined and includes strokes with unknown sources which have not been fully evaluated or have more than one potential cause. About 1 in 6 ischemic strokes is an ESUS. Patient who suffer from ESUS tend to be slightly younger than stroke patients in general and strokes are less severe on average. However, the risk of stroke recurrence after ESUS is high: Within 5 years, nearly 1 in 3 patients may again suffer another stroke.


read more

Stroke Support Organisation Faculty Tool website is now live

Brussels, 16 April 2018- The Stroke Support Organisation Faculty Tool (SSOFT) website goes live today at the following address www.ssoft.info.

The website is a gateway to the new and innovative online eLearning advocacy tool being developed by Stroke Alliance for Europe (SAFE), in partnership with the European Stroke Organisation (ESO).


read more